Indications
Therapeutic Asset Ratings
18,140 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Tranexamic Acid
Injury
Daniel Nishijima, MD, MAS
P3
B
(63)
Treosulfan
Acute Myeloid Leukemia
Institut Paoli-Calmettes
P3
B
(63)
Tretinoin
Non-Small Cell Lung Carcinoma
Peking University People's Hospital
P3
B
(63)
Tucatinib
Breast Carcinoma
Dana-Farber Cancer Institute
P3
B
(63)
Valaciclovir
Non-Small Cell Lung Carcinoma
Candel Therapeutics, Inc.
P3
B
(63)
Veliparib
Squamous Cell Lung Carcinoma
AbbVie
P3
B
(63)
Vepdegestrant
Breast Cancer
Pfizer
P3
B
(63)
Vinblastine
Hodgkin'S Lymphoma, Mixed Cellularity
National Cancer Institute (NCI)
P3
B
(63)
Vinblastine
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
B
(63)
Vinblastine
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)
P3
B
(63)
Vinblastine
Hodgkin'S Lymphoma, Lymphocytic-Histiocytic Predominance
National Cancer Institute (NCI)
P3
B
(63)
(+)-Vincristine
Childhood Acute Lymphoblastic Leukemia
University of Chicago
P3
B
(63)
(+)-Vincristine
Hepatoblastoma
University of Birmingham
P3
B
(63)
(+)-Vincristine
High Grade B-Cell Lymphoma
OHSU Knight Cancer Institute
P3
B
(63)
(+)-Vincristine
Marginal Zone Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
B
(63)
Vincristine Sulfate
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
B
(63)
Vinorelbine Ditartrate
Triple-Negative Breast Carcinoma
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
P3
B
(63)
Vipivotide Tetraxetan
Castration-Resistant Prostate Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(63)
Vipivotide Tetraxetan
Renal Cell Carcinoma
Ankara University
P3
B
(63)
Vipivotide Tetraxetan
Prostate Neoplasm
Novartis Pharmaceuticals
P3
B
(63)
Volitinib
Papillary Renal Cell Carcinoma
AstraZeneca
P3
B
(63)
Vorinostat
Acute Myeloid Leukemia
Medical College of Wisconsin
P3
B
(63)
Zanzalintinib
Pancreatic Neuroendocrine Tumor
Exelixis
P3
B
(63)
Ziftomenib
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P3
B
(63)
Adriamycin
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
P2
B
(63)
Showing 2876 to 2900 of 18,140 assets
Previous
Page 116 of 726
Next